Your session is about to expire
← Back to Search
Virus Therapy
1 for Human Immunodeficiency Virus Infection
Phase 1
Waitlist Available
Led By Ken Nedd, M.D.
Research Sponsored by GAAD Medical Research Institute Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* 1 Year and above
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
The investigators are proposing that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of killer cells to fight and destroy the human immunodeficiency virus.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Infrared Radiation, wavelength between 5 and 20 microns
Find a Location
Who is running the clinical trial?
GAAD Medical Research Institute Inc.Lead Sponsor
21 Previous Clinical Trials
92 Total Patients Enrolled
Ken Nedd, M.D.Principal InvestigatorGAAD Medical Research Institute Inc.
19 Previous Clinical Trials
90 Total Patients Enrolled
Kwasi Donyina, Ph.D.Study DirectorGAAD Medical Research Institute Inc.
13 Previous Clinical Trials
51 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger